Back
Oragenics Vs. SELLAS Life Sciences Group Industry Stock Comparison
Sell
36
OGEN
Oragenics
Last Price:
0.28
Seasonality Move:
14.84%
Sell
47
SLS
SELLAS Life Sciences Group
Last Price:
1.17
Seasonality Move:
12%
Sell
36
Oragenics (OGEN)
is a Sell
Is Oragenics a Buy, Sell or Hold?
- The current Oragenics [OGEN] share price is $0.27. The Score for OGEN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- OGEN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.17. The Score for SLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OGEN Stock Price Chart
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLS is experiencing selling pressure, which indicates risk of future bearish movement.
OGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 35.6 | Sell |
| Chaikin Money Flow: | -1510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.35) | Sell |
| Bollinger Bands (100): | (0.28 - 1.12) | Sell |
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 42.81 | Sell |
| Chaikin Money Flow: | -689516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.28) | Sell |
| Bollinger Bands (100): | (1.16 - 1.28) | Sell |
OGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.3 | Sell |
| 20-day SMA: | 0.32 | Sell |
| 50-day SMA: | 0.36 | Sell |
| 200-day SMA: | 1.2 | Sell |
| 8-day EMA: | 0.3 | Sell |
| 20-day EMA: | 0.32 | Sell |
| 50-day EMA: | 0.43 | Sell |
| 200-day EMA: | 1.42 | Sell |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.26 | Sell |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.25 | Sell |
Oragenics Earnings Growth & OGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.
Oragenics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SELLAS Life Sciences Group Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||